Compare RFL & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RFL | AMTX |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.6M | 109.8M |
| IPO Year | 2017 | 2023 |
| Metric | RFL | AMTX |
|---|---|---|
| Price | $2.14 | $1.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 307.5K | ★ 1.4M |
| Earning Date | 06-10-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.28 | ★ 32.98 |
| EPS | N/A | ★ N/A |
| Revenue | $917,000.00 | ★ $77,194,000.00 |
| Revenue This Year | N/A | $49.77 |
| Revenue Next Year | N/A | $57.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 43.96 | ★ 174.60 |
| 52 Week Low | $1.12 | $1.30 |
| 52 Week High | $3.96 | $3.80 |
| Indicator | RFL | AMTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.94 | 32.40 |
| Support Level | $1.21 | $1.36 |
| Resistance Level | $3.96 | $1.65 |
| Average True Range (ATR) | 0.37 | 0.12 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 0.47 | 0.00 |
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.